290 related articles for article (PubMed ID: 33310281)
1. Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.
Caputo F; Mehn D; Clogston JD; Rösslein M; Prina-Mello A; Borgos SE; Gioria S; Calzolai L
J Chromatogr A; 2021 Jan; 1635():461767. PubMed ID: 33310281
[TBL] [Abstract][Full Text] [Related]
2. Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity.
Caputo F; Clogston J; Calzolai L; Rösslein M; Prina-Mello A
J Control Release; 2019 Apr; 299():31-43. PubMed ID: 30797868
[TBL] [Abstract][Full Text] [Related]
3. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.
Mildner R; Hak S; Parot J; Hyldbakk A; Borgos SE; Some D; Johann C; Caputo F
Eur J Pharm Biopharm; 2021 Jun; 163():252-265. PubMed ID: 33745980
[TBL] [Abstract][Full Text] [Related]
4. Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.
Caputo F; Arnould A; Bacia M; Ling WL; Rustique E; Texier I; Mello AP; Couffin AC
Mol Pharm; 2019 Feb; 16(2):756-767. PubMed ID: 30604620
[TBL] [Abstract][Full Text] [Related]
5. Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation.
Parot J; Caputo F; Mehn D; Hackley VA; Calzolai L
J Control Release; 2020 Apr; 320():495-510. PubMed ID: 32004590
[TBL] [Abstract][Full Text] [Related]
6. The utility of asymmetric flow field-flow fractionation for preclinical characterization of nanomedicines.
Hu Y; Crist RM; Clogston JD
Anal Bioanal Chem; 2020 Jan; 412(2):425-438. PubMed ID: 31776639
[TBL] [Abstract][Full Text] [Related]
7. Advanced nanomedicine characterization by DLS and AF4-UV-MALS: Application to a HIV nanovaccine.
Klein M; Menta M; Dacoba TG; Crecente-Campo J; Alonso MJ; Dupin D; Loinaz I; Grassl B; Séby F
J Pharm Biomed Anal; 2020 Feb; 179():113017. PubMed ID: 31816470
[TBL] [Abstract][Full Text] [Related]
8. Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS).
Ansar SM; Mudalige T
Int J Pharm; 2020 Jan; 574():118906. PubMed ID: 31805309
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric flow field-flow fractionation (AF4) with fluorescence and multi-detector analysis for direct, real-time, size-resolved measurements of drug release from polymeric nanoparticles.
Shakiba S; Astete CE; Cueto R; Rodrigues DF; Sabliov CM; Louie SM
J Control Release; 2021 Oct; 338():410-421. PubMed ID: 34453956
[TBL] [Abstract][Full Text] [Related]
10. The Power of Field-Flow Fractionation in Characterization of Nanoparticles in Drug Delivery.
Bian J; Gobalasingham N; Purchel A; Lin J
Molecules; 2023 May; 28(10):. PubMed ID: 37241911
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticle Size Distribution and Stability Assessment Using Asymmetric-Flow Field-Flow Fractionation.
Hansen M; Clogston JD
Methods Mol Biol; 2024; 2789():21-29. PubMed ID: 38506987
[TBL] [Abstract][Full Text] [Related]
12. Measuring particle concentration of multimodal synthetic reference materials and extracellular vesicles with orthogonal techniques: Who is up to the challenge?
Vogel R; Savage J; Muzard J; Camera GD; Vella G; Law A; Marchioni M; Mehn D; Geiss O; Peacock B; Aubert D; Calzolai L; Caputo F; Prina-Mello A
J Extracell Vesicles; 2021 Jan; 10(3):e12052. PubMed ID: 33473263
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric flow field-flow fractionation as a multifunctional technique for the characterization of polymeric nanocarriers.
Quattrini F; Berrecoso G; Crecente-Campo J; Alonso MJ
Drug Deliv Transl Res; 2021 Apr; 11(2):373-395. PubMed ID: 33521866
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case.
Qu H; Wang J; Wu Y; Zheng J; Krishnaiah YSR; Absar M; Choi S; Ashraf M; Cruz CN; Xu X
Int J Pharm; 2018 Mar; 538(1-2):215-222. PubMed ID: 29341918
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical Flow Field-Flow Fractionation for Sizing of Gold Nanoparticles in Suspension.
Drexel R; Sogne V; Dinkel M; Meier F; Klein T
J Vis Exp; 2020 Sep; (163):. PubMed ID: 32986039
[TBL] [Abstract][Full Text] [Related]
16. Advanced analysis of polymer emulsions: Particle size and particle size distribution by field-flow fractionation and dynamic light scattering.
Makan AC; Spallek MJ; du Toit M; Klein T; Pasch H
J Chromatogr A; 2016 Apr; 1442():94-106. PubMed ID: 26987415
[TBL] [Abstract][Full Text] [Related]
17. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
[TBL] [Abstract][Full Text] [Related]
18. Asymmetrical flow field-flow fractionation with multi-angle light scattering detection for the analysis of structured nanoparticles.
Zattoni A; Rambaldi DC; Reschiglian P; Melucci M; Krol S; Garcia AM; Sanz-Medel A; Roessner D; Johann C
J Chromatogr A; 2009 Dec; 1216(52):9106-12. PubMed ID: 19576590
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric flow field-flow fractionation in the field of nanomedicine.
Wagner M; Holzschuh S; Traeger A; Fahr A; Schubert US
Anal Chem; 2014 Jun; 86(11):5201-10. PubMed ID: 24802650
[TBL] [Abstract][Full Text] [Related]
20. Characterization of dextran particle size: How frit-inlet asymmetrical flow field-flow fractionation (FI-AF4) coupled online with dynamic light scattering (DLS) leads to enhanced size distribution.
Ramirez LMF; Rihouey C; Chaubet F; Le Cerf D; Picton L
J Chromatogr A; 2021 Sep; 1653():462404. PubMed ID: 34348206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
